A Novel Magnetically Targeted Intramedullary (MagIC‐TI) Xenograft Model for Precise Leukemia Modeling and Drug Resistance Evaluation in the Bone Marrow Niche
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/3236026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 28.06.2026. Verfasst von Qiusui Mai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China, sysu.edu.cn. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Bone Marrow, Leukemia, Myeloid, Acute. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Research Start-up Fund of Post-doctoral of SAHSYSU, Innovation Program for Undergraduates of Southern Medical University.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) remains a therapeutic challenge due to drug resistance and relapse, which are often driven by the protective bone marrow (BM) niche. Conventional xenograft models fail to adequately recapitulate this niche‐specific pathophysiology. To overcome this limitation, a novel magnetically targeted intramedullary (MagIC‐TI) xenograft model was developed. Magnetically labeled doxorubicin (DOX)‐resistant HL60 cells (Mag‐Re) were injected into the femurs of NSG (nonobese diabetic [NOD] Cg‐Prkdc scid IL2rg tm1Wjl /SzJ) mice using a patented microinjection syringe under localized magnetic guidance. With the MagIC‐TI model, rapid (day 1) and specific (100% by day 7) leukemic engraftment was achieved within the femoral BM, whereas intravenous (IV) injection led to delayed (mean 23.67 ± 10.26 days) and disseminated engraftment. Bioluminescence imaging, histopathological analysis, flow cytometry, and molecular assays confirmed that disease was localized in the MagIC‐TI model. In contrast, extramedullary infiltration, predominantly in the lungs, spleen, liver, and kidneys, was observed early in progression in the IV model. The MagIC‐TI model discriminated drug responses, showing effective tumor burden reduction with homoharringtonine (HHT) and unequivocal DOX resistance, a distinction that was obscured in heterogeneous IV models. Furthermore, employing a semisolid decalcification (SSD) system preserved green fluorescent protein (GFP) fluorescence, enabling high‐resolution visualization of engrafted cells within bone tissue. The MagIC‐TI model enables BM‐targeted, rapid, and efficient leukemic engraftment and allows discrimination of drug sensitivity and resistance. This model provides a robust and reproducible platform for modeling the leukemia BM niche and for preclinical evaluation of niche‐directed therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Blood Transfusion, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China, sysu.edu.cn.
- First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China, fimmu.com.
- Southern Medical University, Guangzhou, 510515, China, fimmu.com.
- Class of 2022, Eight-Year Clinical Medicine Program, Southern Medical University, Guangzhou, 510515, China, fimmu.com.
- School of Stomatology, Southern Medical University, Guangzhou, 510515, China, fimmu.com.
- Guangzhou Maishi Biotechnology Co., Ltd., Guangzhou, 510515, China.
ORCID-Profile: Qiusui Mai, Taosong Liu, Luxia Tang, Lihan Dai, Siyi Li, Jingyi Guo, Wen Xia, Lingxi Chen, Jiabao Wu, Jiawei Rong, Weishen Zhang, Jiaxing Zhang, Xiaojun Xu, Qianli Jiang
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Research Start-up Fund of Post-doctoral of SAHSYSU
- Innovation Program for Undergraduates of Southern Medical University
Zitieren
APA
Mai, Q., Liu, T., Tang, L., Dai, L., Li, S., Guo, J., Xia, W., Chen, L., Wu, J., Rong, J., Zhang, W., Zhang, J., Xu, X., & Jiang, Q. (2026). A Novel Magnetically Targeted Intramedullary (MagIC‐TI) Xenograft Model for Precise Leukemia Modeling and Drug Resistance Evaluation in the Bone Marrow Niche. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/3236026
Vancouver
Mai Q, Liu T, Tang L, Dai L, Li S, Guo J, et al. A Novel Magnetically Targeted Intramedullary (MagIC‐TI) Xenograft Model for Precise Leukemia Modeling and Drug Resistance Evaluation in the Bone Marrow Niche. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/3236026
BibTeX
@article{Mai2026,
author = {Mai, Qiusui and Liu, Taosong and Tang, Luxia and Dai, Lihan and Li, Siyi and Guo, Jingyi and Xia, Wen and Chen, Lingxi and Wu, Jiabao and Rong, Jiawei and Zhang, Weishen and Zhang, Jiaxing and Xu, Xiaojun and Jiang, Qianli},
title = {A Novel Magnetically Targeted Intramedullary (MagIC‐TI) Xenograft Model for Precise Leukemia Modeling and Drug Resistance Evaluation in the Bone Marrow Niche},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/3236026}
}
EUVIMED